CONSIDERATIONS TO KNOW ABOUT API PHARMACEUTICAL

“The existing situation has exposed some structural weaknesses in the EU’s medicines offer chain plus a significant dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides said. She recommended that supply chain problems be resolved within an EU pharmaceutical strategy anticipated to get released by th